Abstract
This Frost & Sullivan research service titled The Emerging European Molecular POC Testing Markets analyses the POC molecular and infectious disease markets, their competitive structure and strategic viewpoint. In this research, Frost & Sullivan' s expert analysts thoroughly examine the following applications: infectious disease testing, cancer diagnostics (molecular oncology) and pharmacogenomics.
This analysis is available through our Drug Discovery Technologies Growth Partnership Services programme. With this programme, clients receive industry-leading market research such as this, along with technical and econometric data and many interactive features including Analyst Inquiry Time and Client Councils.
Table of Contents
1. Introduction to POC Testing
- 1. Overview of Emerging POC Market
- 1. Introduction to POC Testing Market
2. Point-of-care Molecular Testing
- 1. Point-of-care Molecular Diagnostics
- 1. Dynamics of Molecular Testing
- 2. Applications of Point-of-care Molecular Testing
- 3. End-user Study
3. Spotlight: Molecular Tests for Infectious Diseases Detection
- 1. Point-of-care Tests for Detection of Infectious Diseases
- 1. Success of Molecular Diagnostics in the Detection of Infectious Agents
- 2. Competitive Analysis
- 3. Ongoing Academic and Industrial Research
4. Chlamydial Infections Testing
- 1. Special Focus on Chlamydial Infections Testing
- 1. Introduction to Chlamydial Infection
- 2. Rapid POCT for Detection of Chlamydial infection
- 3. Companies Dedicated Towards Detection of Chlamydia Infection
5. Strategic Viewpoint
- 1. Strategic Recommendation
- 1. Strategic Recommendation
